Attovia Therapeutics, Inc.
ATTO
$19.74
$0.562.89%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 16.51M | 11.70M | |||
| Gross Profit | -16.51M | -11.70M | |||
| SG&A Expenses | 3.21M | 4.25M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.96M | 16.10M | |||
| Operating Income | -19.96M | -16.10M | |||
| Income Before Tax | -18.66M | -15.15M | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.66M | -15.15M | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.66M | -15.15M | |||
| EBIT | -19.96M | -16.10M | |||
| EBITDA | -19.71M | -15.96M | |||
| EPS Basic | -0.48 | -0.43 | |||
| Normalized Basic EPS | -0.30 | -0.27 | |||
| EPS Diluted | -0.48 | -0.43 | |||
| Normalized Diluted EPS | -0.30 | -0.27 | |||
| Average Basic Shares Outstanding | 38.58M | 35.36M | |||
| Average Diluted Shares Outstanding | 38.58M | 35.36M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||